This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Leukaemia of unspecified cell type
C3_LEUKAEMIA_NAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
869 |
4. Check minimum number of eventsNone |
869 |
5. Include endpointsNone |
869 |
6. Filter based on genotype QC (FinnGen only) |
330 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Leuc(h)aemiae typo cellulari non specificato
Similar endpoints
↥List of similar endpoints to
Leukaemia of unspecified cell type
based on the number of shared cases.
Similar with more cases:
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 330 | 144 | 186 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.09 |
| Median age at first event (years) | 65.21 | 60.95 | 68.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 357
- Matched controls
- 3570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
60.7
307.7
228
101
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
247.8
208
*
XW000
NOMESCO Finland
Bone marrow biopsy
40.6
247.6
172
80
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
304.7
140.0
134
7
C95.9
ICD-10 Finland
Leukaemia, unspecified
1642.3
123.6
113
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
24.5
115.5
88
47
WW500
NOMESCO Finland
Blood transfusion
17.2
114.9
108
88
L03AA02
ATC
filgrastim; parenteral
17.7
84.3
74
52
L01BB02
ATC
mercaptopurine; oral
44.6
82.6
50
13
A05AA02
ATC
ursodeoxycholic acid; oral
30.3
76.5
52
20
127
Kela drug reimbursment
Transplant complication
34.5
73.9
48
16
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
294.2
72.2
71
*
A04AA01
ATC
ondansetron; systemic, rectal
8.4
64.5
101
161
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
152.4
61.1
63
5
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
25.6
57.1
41
18
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.4
54.1
80
118
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
20.9
52.5
41
22
M04AA01
ATC
allopurinol; systemic
5.6
50.2
127
320
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
47.4
120
301
J05AB11
ATC
valaciclovir; oral
5.1
42.9
119
320
L04AD01
ATC
ciclosporin; systemic
18.4
42.4
35
21
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
85.3
41.0
45
6
L01XX05
ATC
hydroxycarbamide; oral
16.1
39.6
35
24
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
12.8
38.5
39
34
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.8
37.8
66
115
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
211.9
37.6
38
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
141.3
36.5
38
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
+∞
35.0
33
*
ZX120
NOMESCO Finland
Intravenous
5.2
33.2
80
188
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.8
32.2
43
55
A41.9
ICD-10 Finland
Sepsis, unspecified
7.6
30.5
46
68
R50.9
ICD-10 Finland
Fever, unspecified
3.9
28.7
112
377
TAB00
NOMESCO Finland
Lumbar puncture
7.0
28.7
47
76
H02AB09
ATC
hydrocortisone; systemic
9.6
28.5
35
40
WW200
NOMESCO Finland
Immunization
9.9
26.9
32
35
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
279.8
26.1
26
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
38.9
25.7
32
9
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
25.2
86
262
189
Kela drug reimbursment
Imatinib
128.3
22.9
24
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
22.8
109
412
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.3
22.0
48
102
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
21.5
80
257
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
116.9
20.8
22
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
20.3
221
1297
J01MA12
ATC
levofloxacin; systemic
3.1
19.3
108
444
J02AC03
ATC
voriconazole; systemic
36.6
19.1
24
7
B73
ICPC
Leukaemia
105.7
18.8
20
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
18.9
18.6
28
16
JN4AD
NOMESCO Finland
Body CT examination
3.5
18.5
73
242
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
17.9
17
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
189.0
17.7
18
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
189.0
17.7
18
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.6
17.6
35
68
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.5
16.9
44
108
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
37.0
16.9
21
6
J02AC04
ATC
posaconazole; systemic
+∞
16.8
16
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
14.4
16.8
28
21
L01XE01
ATC
[U] imatinib
94.6
16.7
18
*
H02AB02
ATC
dexamethasone; systemic
3.4
16.4
66
221
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.4
15.8
27
45
ZXD05
NOMESCO Finland
Urgent procedure
2.5
15.1
139
723
212
Kela drug reimbursment
Gout
6.9
15.1
24
37
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.3
15.0
26
44
L01EA01
ATC
imatinib; oral
83.6
14.7
16
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
21.1
13.9
20
10
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
13.6
13
*
316
Kela drug reimbursment
Imatinib
+∞
13.6
13
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
13.3
121
621
TPH00
NOMESCO Finland
Phlebotomy
41.8
13.3
16
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
29.6
13.1
17
6
J05AB01
ATC
aciclovir; systemic
2.5
12.9
102
489
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.4
12.9
34
84
N02AA05
ATC
oxycodone; systemic
2.5
12.8
98
463
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
12.6
12
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
134.5
12.5
13
*
Z51.5
ICD-10 Finland
Palliative care
3.1
12.2
55
196
ZX121
NOMESCO Finland
Central venous catheter
27.8
12.1
16
6
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
23.8
11.7
16
7
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
11.5
11
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
11.5
11
*
152
Kela drug reimbursment
Nilotinib
+∞
11.5
11
*
ZX112
NOMESCO Finland
Subcutaneous
5.8
11.3
21
38
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.7
11.2
20
18
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.4
11.1
29
71
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
22.3
10.8
15
7
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
10.7
29
73
ZX131
NOMESCO Finland
Intrathecal
61.9
10.7
12
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
10.5
10
*
2089X
ICD-9 Finland
Leukaemia of unspecified cell type, Unspecified leukaemia
+∞
10.5
10
*
J01MA14
ATC
moxifloxacin; systemic
2.9
10.4
52
196
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.9
10.3
32
89
1518, ,
Kela drug reimbursment
20.7
9.9
14
7
H02AB04
ATC
methylprednisolone; systemic
2.5
9.7
66
292
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.8
9.7
22
48
D70.89
ICD-10 Finland
Neutropenic splenomegaly
10.5
9.6
18
18
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
15.6
9.6
15
10
L04AX03
ATC
methotrexate; systemic
2.9
9.6
48
181
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
102.6
9.5
10
*
150
Kela drug reimbursment
Dasatinib
102.6
9.5
10
*
399
Kela drug reimbursment
Venetoclax
19.2
9.0
13
7
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
13.0
8.9
15
12
L04AA01
ATC
[U] ciclosporin
13.0
8.9
15
12
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
8.9
37
125
A41.8
ICD-10 Finland
Other specified sepsis
6.7
8.6
21
33
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
16.8
8.6
13
8
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
92.1
8.4
9
*
L01EA02
ATC
dasatinib; oral
92.1
8.4
9
*
L01EA03
ATC
nilotinib; oral
+∞
8.4
8
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
8.1
53
229
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.5
8.1
18
25
JN4BD
NOMESCO Finland
Extensive body CT
2.5
8.0
53
231
C90.0
ICD-10 Finland
Multiple myeloma
8.3
7.7
16
20
L01XX52
ATC
venetoclax; oral
18.9
7.6
11
6
SPAT1074
SPAT
Venesection
18.9
7.6
11
6
5BA08, ,
NOMESCO Finland
25.6
7.6
10
*
ZX114
NOMESCO Finland
Intramuscular
7.9
7.5
16
21
L01XE06
ATC
[U] dasatinib
81.7
7.4
8
*
2AA01, ,
NOMESCO Finland
81.7
7.4
8
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
13.7
7.4
12
9
328
Kela drug reimbursment
Nilotinib
+∞
7.3
7
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
7.3
7
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
7.3
7
*
J05AX18
ATC
letermovir; oral
+∞
7.3
7
*
L01XE08
ATC
[U] nilotinib
+∞
7.3
7
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
7.3
131
840
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
30.7
7.2
9
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
20.5
7.2
10
5
L04AA06
ATC
mycophenolic acid; systemic
7.2
7.1
16
23
J02AC01
ATC
fluconazole; systemic
1.9
7.0
121
763
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
6.9
147
988
1XX02, ,
NOMESCO Finland
40.8
6.8
8
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
40.8
6.8
8
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.3
6.6
17
41
L04AD02
ATC
tacrolimus; systemic
12.6
6.6
11
9
L01BA01
ATC
methotrexate; systemic
4.0
6.6
19
50
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
6.5
38
155
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.9
6.5
31
114
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
6.5
39
162
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
71.1
6.4
7
*
1DB06, ,
NOMESCO Finland
71.1
6.4
7
*
D11AH01
ATC
tacrolimus; topical
14.6
6.4
10
7
WW409
NOMESCO Finland
Other aferesis
18.4
6.3
9
5
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
6.3
6
*
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
6.3
6
*
B74
ICPC
Malignant neoplasm blood other
+∞
6.3
6
*
9837/3-C42.1
ICD-O-3
Precursor T-cell lymphoblastic leukemia of bone marrow
+∞
6.3
6
*
C95.2
ICD-10 Finland
Subacute leukemia of unspecified cell type
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
6.3
53
257
122
Kela drug reimbursment
Aplastic anaemia
27.2
6.3
8
*
Z2446
NOMESCO Finland
Social worker
2.7
6.2
34
134
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
115
57
29.29
157.67
5.3
1.6
—
—
—
0
0
93
62
19.93
109.95
1.5
1.3
133.41
143.97
au/ml
0.20
28
21
92
66
18.43
104.53
13.2
6.5
244.70
142.33
iu/ml
—
20
9
90
67
17.62
100.08
1.3
1.2
255.62
248.04
u/ml
0.04
56
27
157
330
7.71
78.95
7.5
3.1
60.35
67.93
e9/l
1.21
124
250
86
90
12.27
76.86
1.7
1.8
—
—
—
0
0
80
98
10.23
63.32
3.8
1.6
—
—
—
0
0
60
57
12.45
56.57
4.0
1.8
—
—
—
0
0
160
452
5.60
56.17
15.4
5.9
1.11
1.08
mmol/l
0.59
155
415
69
91
9.16
51.12
3.4
1.6
—
—
—
0
0
164
515
5.04
49.73
12.5
3.7
0.80
0.81
mmol/l
1.15
158
488
83
159
6.50
43.60
1.7
2.1
1.58
1.46
g/l
0.39
65
143
40
30
14.89
43.21
4.2
2.4
—
—
—
0
0
42
35
13.47
42.67
4.3
2.3
—
—
—
0
0
35
23
16.76
40.51
1.1
1.0
—
—
—
0
0
43
42
11.50
39.43
4.3
2.0
—
—
—
0
0
191
786
4.08
38.23
10.3
3.0
310.84
351.50
umol/l
3.36
185
682
106
292
4.74
36.51
11.5
7.6
7.09
9.73
mmol/l
4.50
101
279
33
0
+∞
34.97
1.1
0.0
—
—
—
0
0
39
8
54.50
33.26
1.2
1.0
—
—
—
0
0
148
561
3.80
32.37
4.1
2.0
—
—
—
0
0
34
33
11.28
31.14
1.7
1.3
—
—
—
0
0
89
240
4.61
31.09
3.7
1.5
—
—
—
0
0
35
42
9.13
27.47
2.1
1.4
—
—
—
0
0
155
663
3.36
27.20
5.5
1.7
3.49
1.53
mg/l
1.62
139
528
35
43
8.92
26.96
2.3
1.3
—
—
—
0
0
115
421
3.55
25.69
2.9
1.9
—
—
—
0
0
41
68
6.68
24.32
7.6
1.3
1.52
15.04
e6/l
0.70
29
49
41
70
6.49
23.64
7.6
1.4
7.80
526.25
e6/l
0.96
30
51
50
106
5.32
22.98
2.6
1.2
—
—
—
0
0
44
85
5.76
22.36
1.6
1.5
—
—
—
0
0
27
31
9.34
21.81
5.3
2.0
—
—
—
0
0
27
31
9.34
21.81
5.3
2.0
—
—
—
0
0
27
31
9.34
21.81
5.3
2.0
—
—
—
0
0
103
394
3.27
20.97
2.9
2.0
—
—
—
0
0
35
63
6.05
19.07
7.6
1.2
3.53
3.80
mmol/l
0.76
35
57
25
9
29.72
18.99
2.1
1.1
—
—
—
0
0
233
1435
2.80
18.97
19.7
7.2
1.20
1.21
mmol/l
1.52
224
1321
263
1740
2.94
18.37
47.5
10.0
3.83
4.17
e9/l
0.20
248
1508
24
31
8.23
17.63
1.2
1.1
—
—
—
0
0
144
724
2.66
17.25
11.7
2.5
—
—
—
0
0
219
1354
2.60
16.92
15.5
5.2
33.62
35.40
g/l
4.98
214
1273
243
1587
2.66
16.62
22.3
7.9
1.20
1.21
mmol/l
0.96
212
1378
27
19
15.27
16.60
4.0
2.9
—
—
—
0
0
36
77
5.09
16.26
1.5
2.3
16.21
12.75
mg/l
0.47
28
72
27
21
13.81
15.95
1.4
1.8
—
—
—
0
0
27
21
13.81
15.95
1.4
1.8
—
—
—
0
0
33
68
5.25
15.54
1.6
1.6
—
—
—
0
0
90
373
2.89
15.48
16.1
3.0
11.09
8.63
umol/l
0.31
85
335
216
1362
2.48
15.46
11.1
2.9
—
—
estimate
—
0
0
13
0
+∞
13.63
13.8
0.0
—
—
—
0
0
28
56
5.34
13.60
1.5
1.6
—
—
—
0
0
32
74
4.65
13.16
1.6
1.5
—
—
—
0
0
40
116
3.76
12.21
2.6
3.0
—
—
—
0
0
124
676
2.28
11.58
2.1
1.4
1.85
2.59
g/l
5.13
106
381
21
21
10.55
11.16
6.7
3.6
1.52
0.95
%
0.81
21
21
53
196
3.00
10.99
3.2
1.8
—
—
—
0
0
38
115
3.58
10.88
4.5
4.0
104.69
36.07
mg/l
0.44
32
101
38
115
3.58
10.88
4.5
4.0
54.11
110.61
mg/l
0.52
32
100
36
106
3.66
10.73
4.6
3.5
3.89
3.26
ratio
0.08
19
57
139
836
2.09
9.83
2.2
2.3
3.01
2.88
mg/l
0.32
124
732
38
123
3.34
9.81
6.1
2.1
—
—
—
0
0
36
113
3.43
9.75
3.1
1.9
—
—
—
0
0
207
1451
2.02
9.44
18.3
15.4
1.24
1.29
inr
0.67
184
1209
16
14
11.90
9.15
7.6
2.5
—
—
—
0
0
16
14
11.90
9.15
7.6
2.5
—
—
—
0
0
17
17
10.44
9.12
7.5
2.3
—
—
—
0
0
17
17
10.44
9.12
7.5
2.3
—
—
—
0
0
17
17
10.44
9.12
7.5
2.3
—
—
—
0
0
17
17
10.44
9.12
7.5
2.3
—
—
—
0
0
16
15
11.11
8.88
7.6
2.4
—
—
—
0
0
196
1371
1.95
8.74
4.8
3.1
480.22
131.15
ug/l
8.22
186
1267
151
967
1.97
8.73
5.1
2.7
54.62
62.16
u/l
0.65
145
897
11
5
22.63
8.06
1.8
1.6
—
—
—
0
0
7
0
+∞
7.31
5.9
0.0
—
—
—
0
0
17
26
6.81
7.20
2.0
1.1
—
—
—
0
0
26
81
3.38
7.12
1.2
1.5
210.80
241.55
miu/ml
—
5
36
28
93
3.18
6.94
3.7
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
90
3.16
6.65
5.9
2.3
0.24
0.39
iu/ml
2.15
18
51
14
19
7.62
6.47
3.4
1.4
—
—
—
0
0
14
19
7.62
6.47
3.4
1.4
—
—
—
0
0
10
7
14.65
6.43
1.2
1.4
—
—
—
0
0
13
16
8.38
6.38
3.5
1.3
—
—
—
0
0
13
16
8.38
6.38
3.5
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
10
8
12.81
6.11
1.4
1.1
71.30
127.88
%
—
10
8
17
33
5.35
6.09
1.4
1.6
—
—
—
0
0
17
36
4.90
5.69
5.2
1.6
—
—
—
0
0
9
7
13.14
5.61
1.1
2.6
—
—
—
0
0
17
37
4.77
5.56
5.2
1.6
—
—
—
0
0
17
37
4.77
5.56
5.2
1.6
—
—
—
0
0
11
14
8.07
5.38
1.2
1.6
—
—
—
0
0
109
717
1.75
5.27
3.8
2.8
5.13
5.35
e6/l
0.06
103
652
13
22
6.09
5.27
1.8
1.3
—
—
—
0
0
242
1970
1.71
5.21
6.0
5.1
22.00
2121.09
e6/l
—
6
34
47
239
2.11
4.92
5.7
3.8
0.69
1.52
mmol/l
0.72
40
174
10
14
7.31
4.68
1.5
2.2
84.80
101.86
%
—
10
14
7
5
14.24
4.59
1.6
1.4
—
—
—
0
0
15
37
4.19
4.46
5.8
1.6
—
—
—
0
0
15
37
4.19
4.46
5.8
1.6
—
—
—
0
0
86
554
1.73
4.39
1.9
1.7
1153.11
1153.00
nmol/l
0.00
76
421
15
38
4.07
4.35
5.8
1.6
—
—
—
0
0
18
62
3.00
4.23
2.0
1.3
—
—
—
0
0
14
41
3.51
4.23
1.0
1.1
—
—
—
0
0
19
68
2.89
4.19
1.2
1.4
—
—
—
0
0
130
942
1.60
4.19
2.0
1.7
17.03
20.88
nmol/l
2.79
125
783
141
1049
1.57
4.02
3.5
3.4
1184.99
1412.04
ng/l
0.46
126
894
21
82
2.66
3.96
2.8
1.9
10.10
7.86
u/l
0.42
14
65
139
1035
1.56
3.93
5.7
3.4
2.31
2.35
mmol/l
3.42
134
926
140
1045
1.56
3.91
5.5
3.6
33.06
111.65
e6/l
0.66
117
804
22
89
2.57
3.88
1.1
1.3
—
—
—
0
0
172
1346
1.54
3.87
2.4
2.2
92.59
94.24
pmol/l
0.17
125
704
14
45
3.20
3.69
1.5
1.2
8.40
5.24
u/ml
—
5
21
9
16
5.74
3.68
1.4
1.3
—
—
—
0
0
61
374
1.76
3.68
10.4
9.4
1.14
0.80
mmol/l
0.37
48
309
33
165
2.10
3.63
1.5
1.4
—
—
—
0
0
21
87
2.50
3.54
1.2
1.5
—
—
—
0
0
9
17
5.40
3.53
1.4
1.3
—
—
—
0
0
8
14
5.82
3.36
13.9
3.9
239.38
210.29
u/l
—
8
14
6
7
8.69
3.27
1.0
1.0
—
—
—
0
0
56
348
1.72
3.22
17.8
4.3
1.24
1.61
mmol/l
0.26
48
283
8
15
5.43
3.21
2.5
1.1
—
—
—
0
0
89
624
1.57
3.19
5.2
4.2
533.33
313.69
ng/l
0.26
78
510
9
20
4.59
3.13
1.4
1.3
—
—
—
0
0
120
903
1.50
3.09
5.5
3.5
0.91
0.48
e6/l
0.45
98
661
16
63
2.61
3.00
1.4
1.3
—
—
—
0
0
16
63
2.61
3.00
1.4
1.3
—
—
—
0
0
5
6
8.43
2.75
2.6
1.0
—
—
—
0
0
47
293
1.70
2.68
3.2
2.3
91.40
31.86
u/l
0.45
42
238
38
223
1.79
2.67
24.6
4.4
23.93
23.98
mmol/l
0.03
38
223
88
641
1.49
2.61
1.6
1.8
396.57
21747644.96
pmol/l
0.50
77
538
22
109
2.09
2.52
29.4
4.9
1.20
1.50
mg/l
1.55
22
96
149
1211
1.40
2.43
4.4
4.2
50.36
83.19
ng/l
0.30
123
897
6
13
4.67
2.28
2.0
1.2
—
—
—
0
0
6
13
4.67
2.28
1.7
1.1
—
—
—
0
0
9
29
3.16
2.24
1.0
1.4
—
—
—
0
0
5
9
5.62
2.22
1.8
1.2
—
—
—
0
0
244
2174
1.39
2.16
6.1
4.5
17.89
12.23
mm/h
4.54
236
2014
6
14
4.34
2.16
1.2
1.1
—
—
—
0
0
6
15
4.05
2.04
2.0
1.1
—
—
—
0
0
256
2778
0.72
1.98
6.0
5.9
2.55
2.62
mmol/l
0.64
244
2556
15
73
2.10
1.83
1.1
1.3
—
—
—
0
0
186
1614
1.32
1.83
4.0
4.1
0.03
5.00
estimate
0.49
35
325
12
53
2.31
1.82
1.1
1.2
—
—
—
0
0
12
53
2.31
1.82
1.1
1.2
—
132.00
—
0
5
8
29
2.80
1.80
1.1
1.2
—
—
—
0
0
184
1601
1.31
1.75
4.0
4.1
0.00
0.00
estimate
-0.00
33
311
187
1631
1.31
1.74
4.0
4.2
0.00
0.01
estimate
0.50
33
297
7
24
2.95
1.73
1.4
2.0
—
—
—
0
0
5
13
3.88
1.72
15.4
2.8
4.49
4.59
kpa
—
5
13
5
13
3.88
1.72
15.4
2.8
8.86
10.68
kpa
—
5
13
8
31
2.62
1.67
1.1
1.2
—
—
—
0
0
8
31
2.62
1.67
1.1
1.2
—
—
—
0
0
8
31
2.62
1.67
1.1
1.2
—
—
—
0
0
7
25
2.83
1.65
1.1
1.1
—
—
—
0
0
252
2720
0.75
1.65
5.5
5.1
1.32
1.44
mmol/l
4.48
238
2492
10
42
2.42
1.63
1.1
1.5
—
—
—
0
0
24
146
1.69
1.55
2.7
3.7
25.04
24.65
mmol/l
0.28
24
141
0
43
0.00
1.53
0.0
1.2
—
2.87
—
0
12
5
15
3.36
1.53
1.6
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
16
3.15
1.44
1.8
1.2
—
—
—
0
0
108
897
1.29
1.40
3.9
4.2
0.00
0.01
estimate
0.50
32
293
242
2606
0.78
1.38
5.6
5.2
2.15
1.94
mu/l
1.19
228
2370
6
23
2.64
1.37
11.3
2.8
0.67
0.96
index
—
6
23
33
226
1.51
1.34
7.3
2.8
65.75
61.76
ml/min/173m2
0.22
20
102
39
277
1.46
1.34
2.4
2.4
3.84
7.73
ug/l
1.60
34
242
293
3073
0.74
1.32
79.4
25.9
3.90
4.48
e12/l
28.46
288
2996
8
35
2.31
1.27
1.1
1.2
—
—
—
0
0
6
25
2.42
1.25
1.8
3.8
12.92
77.91
u/ml
—
6
25
5
19
2.65
1.22
1.0
1.0
—
—
—
0
0
8
38
2.13
1.19
1.1
1.2
—
—
—
0
0
14
81
1.76
1.10
1.1
1.3
—
—
—
0
0
7
32
2.21
1.08
2.1
1.7
3.26
4.40
umol/l
—
7
23
66
533
1.29
1.05
5.6
3.3
1.71
2.11
e6/l
0.24
38
270
15
238
0.61
1.05
1.3
1.4
—
—
—
0
0
9
48
1.90
1.01
1.2
1.6
—
—
—
0
0
86
723
1.25
1.00
3.4
4.4
1.02
1.02
kg/l
0.32
62
480
7
36
1.96
0.97
1.0
1.2
—
—
—
0
0
259
2730
0.81
0.95
6.0
5.2
4.35
4.50
mmol/l
1.68
248
2524
60
491
1.27
0.88
1.2
1.3
2.67
9.12
u/ml
1.77
18
176
6
30
2.02
0.87
11.5
2.9
13.33
13.04
index
—
6
23
99
1126
0.83
0.81
5.0
5.6
2.46
3.02
ug/l
0.27
93
996
102
1154
0.84
0.78
2.5
2.0
1.64
1.35
mmol/l
1.63
92
958
10
59
1.71
0.76
1.9
1.5
—
—
—
0
0
62
733
0.81
0.75
1.3
1.4
2.37
1.36
u/ml
0.29
15
180
253
2651
0.84
0.73
6.0
6.7
39.13
39.87
mmol/mol
0.64
239
2470
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
7
40
1.76
0.71
1.0
1.0
—
—
—
0
0
42
341
1.26
0.68
1.6
1.5
—
—
—
0
0
226
2382
0.86
0.67
68.1
22.3
332.91
332.39
g/l
0.30
226
2371
5
28
1.80
0.66
1.8
3.2
601.00
916.79
mg
—
5
28
258
2688
0.86
0.63
6.8
5.3
5.98
6.02
mmol/l
0.17
242
2445
6
102
0.58
0.63
1.8
1.9
22.17
40.08
nmol/l
—
6
96
34
272
1.28
0.62
3.2
2.7
0.13
0.31
e6/l
2.05
34
261
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
65
560
1.20
0.61
5.8
3.2
0.63
1.00
e6/l
1.05
38
294
79
892
0.85
0.59
4.3
4.6
20.29
21.93
%
0.47
39
434
6
35
1.73
0.58
2.3
1.2
—
—
—
0
0
6
36
1.68
0.57
1.0
1.4
0.45
0.52
nmol/l
—
6
30
288
2966
0.85
0.55
41.1
12.3
28.89
25.93
u/l
2.04
283
2879
131
1209
1.13
0.51
3.3
4.1
0.00
0.02
estimate
0.96
26
262
7
45
1.57
0.49
1.9
3.6
12.14
42.27
u/ml
—
7
45
58
659
0.86
0.47
3.1
3.1
0.57
0.82
ug/l
2.37
39
420
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
41
354
1.18
0.40
4.1
4.9
29.30
31.73
%
0.75
33
226
13
170
0.76
0.39
1.3
1.2
75.83
115.86
u/ml
—
6
59
40
346
1.18
0.39
4.3
4.5
3.44
51.41
ug/l
1.32
30
291
9
71
1.27
0.36
1.3
1.4
0.95
0.77
nmol/l
—
9
60
57
517
1.12
0.30
1.9
1.6
—
—
—
0
0
196
1890
1.08
0.29
5.1
3.5
74.35
49.13
u/l
1.93
185
1769
7
57
1.23
0.29
1.6
1.4
—
—
—
0
0
37
328
1.14
0.28
10.2
8.0
—
—
—
0
0
95
1008
0.92
0.26
3.9
4.1
8.44
10.00
mg/mmol
0.21
68
651
20
171
1.18
0.24
1.3
1.3
—
53.22
—
0
15
22
190
1.17
0.23
2.5
2.5
—
16.54
—
0
14
255
2602
0.93
0.22
6.0
4.4
1.48
1.26
mmol/l
4.18
242
2373
5
41
1.22
0.22
5.6
5.0
242.80
340.83
umol/l
—
5
36
29
258
1.13
0.22
1.7
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.28
—
0
10
8
101
0.79
0.21
1.5
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
7.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
314.60
—
0
5
0
12
0.00
0.21
0.0
1.2
—
8.98
—
0
12
92
878
1.06
0.17
2.9
3.5
0.00
0.01
estimate
0.50
24
250
5
66
0.75
0.17
1.2
1.3
—
—
—
0
0
11
130
0.84
0.16
1.5
1.5
0.24
0.37
mg/l
—
5
52
289
2854
1.07
0.15
59.0
17.3
26.72
25.20
mg/l
0.30
279
2352
7
87
0.80
0.14
1.3
1.6
769.10
918.60
mu/l
—
7
74
8
98
0.81
0.14
2.4
1.9
—
—
—
0
0
33
308
1.08
0.11
6.6
3.4
—
—
—
0
0
6
57
1.05
0.08
3.5
3.2
8.42
10.60
pmol/l
—
6
57
8
91
0.88
0.07
1.3
1.1
1.54
1.53
g/l
—
8
91
11
99
1.11
0.06
1.4
1.2
—
—
—
0
0
17
158
1.08
0.06
1.1
1.0
—
—
—
0
0
13
119
1.10
0.06
1.6
2.3
—
—
—
0
0
17
182
0.93
0.05
30.8
3.8
0.84
0.60
%
1.47
17
182
13
140
0.93
0.04
2.2
2.4
—
—
—
0
0
15
160
0.93
0.04
3.1
4.2
1.02
1.02
ratio
0.14
15
151
11
101
1.09
0.04
1.4
1.2
—
—
—
0
0
55
537
1.03
0.04
1.3
1.3
14.35
29.96
iu/ml
2.28
12
156
16
151
1.06
0.03
1.4
1.3
—
—
—
0
0
175
1739
1.01
0.02
4.0
3.0
—
—
—
0
0
264
2650
0.99
0.02
39.6
16.7
80.22
78.87
ml/min/173m2
0.37
246
2444
217
2177
0.99
0.01
4.5
4.1
14.98
14.86
pmol/l
0.29
202
1958
28
281
1.00
0.00
1.7
2.3
—
—
—
0
0
19
185
1.03
0.00
31.2
3.7
1.22
1.16
%
0.16
19
185
106
1055
1.01
0.00
2.8
3.3
6.71
7.72
mmol/l
1.67
95
892
0
9
0.00
-0.00
0.0
1.0
—
7.86
—
0
9
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
72
0.97
-0.00
1.4
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
9
93
0.97
-0.00
1.4
1.1
0.87
0.91
g/l
—
9
93
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.0
—
59.90
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_LEUKAEMIA_NAS – Leukaemia of unspecified cell type
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).